Evidence map›Paper›PMID 40037366›Full record

ArticleInternational health2025

Kala-azar elimination in India: reflections on success and sustainability.

Dhruv K Pandey, Jorge Alvar, Margriet den Boer, Saurabh Jain, Naresh Gill, Daniel Argaw, Subhash Salunke, Mobassir Hussain, Nupur Roy

Abstract read
In one paragraph

Article in International health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dhruv K PandeyWorld Heal th Organization, Country Office, Pretoria 0002, South Africa.
Jorge AlvarRoyal Academy of Medicine, Madrid 28103, Spain.
Margriet den BoerMédecins Sans Frontières, Amsterdam 1018DD, Netherlands.ORCID 0000-0003-1598-2206
Saurabh JainDepartment of Control of Neglected Tropical Diseases, World Health Organization, Geneva 1211, Switzerland.
Naresh GillDirectorate of National Centre for Disease Control, New Delhi 110054, India.
Daniel ArgawDepartment of Control of Neglected Tropical Diseases, World Health Organization, Geneva 1211, Switzerland.
Subhash SalunkePublic Health Foundation of India, New Delhi 110017, India.
Mobassir HussainDirectorate of National Centre for Disease Control, New Delhi 110054, India.
Nupur RoyDirectorate of National Centre for Disease Control, New Delhi 110054, India.

Funding

World Health Organization 001
6 · The paper itself

Abstract

The incidence and mortality of kala-azar (KA, visceral leishmaniasis) in India have fallen drastically in the past few years, and in 2023 the reported KA incidence reached the threshold for elimination as a public health problem (<1 case/10 000 of population at subdistrict level). One of the strategies adopted by India's kala-azar elimination program (KAEP) was the regular independent assessment of the program implementation by teams of experts. We present the findings of assessments undertaken in 2019, 2021 and 2023, when the KAEP was in the last mile of elimination. Factors that contributed to its success were political commitment, intensified implementation, a strong network of KA partners and committed donors. Bottlenecks were observed in disease surveillance, data utilization, vector-control operations and program management at implementation. To sustain the gains and achieve validation of elimination, the KAEP should continue the following minimal essential services: optimized active and passive case detection and management of KA, post-KA dermal leishmaniasis, KA-HIV coinfection and relapse supported by vector-control interventions. Long-term measures that will sustain elimination are overall socioeconomic development, including improved living conditions, parallel with efficient surveillance and operational research that is aligned with the changing epidemiology of the disease.

Indexed as

Disease EradicationLeishmaniasis, VisceralHumansIncidenceIndiaProgram Evaluationcommunicable disease controlIndialeishmaniasis visceralnational health programsneglected diseasesparasitic diseases

Identifiers

PMID40037366
PMCPMC12212201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.